130 related articles for article (PubMed ID: 12260155)
1. Drug interference with laboratory tests: oral contraceptives.
Sher PP
Drug Ther (NY); 1977 Oct; 2(10):61-3. PubMed ID: 12260155
[TBL] [Abstract][Full Text] [Related]
2. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
3. [Sex steroids and vascular risk].
Rozenbaum H
Coeur; 1983; 14(1):91-102. PubMed ID: 12339512
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
5. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral contraceptives on the nutrient profile of women belonging to high income group.
Vijayalakshmi P; Jose R
Indian J Nutr Diet; 1984 Jul; 21(7):225-32. PubMed ID: 12268340
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
8. [Contraception for the diabetic woman].
Arlot S; Mesmacque A; Lalau JD; Quichaud J
Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
10. [The triphasic pill].
Belaisch J
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):368-72. PubMed ID: 12280209
[TBL] [Abstract][Full Text] [Related]
11. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
12. The effects of an oral contraceptive, ascorbic acid and iron on glucose and copper metabolism in the rat.
Keith MO; Pelletier O
Nutr Rep Int; 1976 Mar; 13(3):273-80. PubMed ID: 12307729
[TBL] [Abstract][Full Text] [Related]
13. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
Bakir R; Hilliquin P
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
[TBL] [Abstract][Full Text] [Related]
14. Restovar--new low-dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy.
Cullberg G; Adelgaard J; Andersen JN; Andersen ES; Berg H; Bergink EW; Buhl G; Pedersen JH; Poulsen L
Contracept Deliv Syst; 1984 Apr; 5(2):97-104. PubMed ID: 12266201
[TBL] [Abstract][Full Text] [Related]
15. The effect of two low-dose oral contraceptives and non-hormonal contraception on serum lipids and high-density lipoprotein cholesterol.
Saure A; Heikkinen JE; Ylostalo P
Contracept Deliv Syst; 1984 Apr; 5(2):83-90. PubMed ID: 12266199
[TBL] [Abstract][Full Text] [Related]
16. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
Boyet F
Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
[TBL] [Abstract][Full Text] [Related]
17. [Are estrogens responsible for incidents observed under combined estrogen-progestagen treatment?].
Cohen J; Bazin C; Rozenbaum J
Fertil Orthog; 1970 Oct; 2(4):17-22. PubMed ID: 12305314
[TBL] [Abstract][Full Text] [Related]
18. Study of plasma renin activity in Indian women using low estrogen combination pill as contraceptive [abstract].
Gupta KC; Suhramaniam M; Jarag PD; Satoskar RS
Indian J Pharmacol; 1982; 14(1):83-4. PubMed ID: 12266190
[TBL] [Abstract][Full Text] [Related]
19. [Contraception for women over 40].
Erny R; Mathet M
Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
[TBL] [Abstract][Full Text] [Related]
20. Effects of a very low-estrogen oral contraceptive on clotting factors, carbohydrate metabolism and plasma lipids and lipoproteins.
Thiery M; Vermeulen A; Baele G; Deslypere JP
Med Sci Res; 1987 Oct 16-31; 15(20):1231-2. PubMed ID: 12282907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
